BD issued an urgent field safety notice in the UK to warn of potential issues with its Alaris neXus V700 infusion pump system. According to the notice, BD identified that the anti-free flow clamp may not activate when the system door opens. This allows for the potential uncontrolled flow of medication. The issue does not […]
BD
AngioDynamics settles patent litigations with BD’s Bard
AngioDynamics entered into a settlement agreement with BD to resolve all patent litigations with Bard. Under terms of the agreement, BD will grant a license to AngioDynamics under certain of BD’s port patents. AngioDynamics will grant BD a license under certain of AngioDynamics’ catheter payments. AngioDynamics will also make a one-time payment of $7 million, […]
BD ups domestic syringe production in wake of FDA warnings on syringes made in China
BD (NYSE:BDX) announced today that it is increasing its U.S. syringe production after the FDA issued warnings related to syringes manufactured in China. In November, the FDA warned of the potential for device failures with plastic syringes manufactured in China. Failures could include leaks, breakage and other problems. The agency said it received information about quality […]
BD names new president of BD Surgery
BD this week announced it appointed Rian Seger as president of BD Surgery, effective April 1. Seger will be responsible for driving the global strategic, operational and commercial performance of BD Surgery and will report to EVP and President of Interventional Rick Byrd. He replaces Brooke Story who is stepping down to focus on personal […]
BD initiates IDE trial of stent for treating peripheral arterial disease
BD announced today that it enrolled the first patient in a trial of its Vascular Covered Stent for treating peripheral arterial disease (PAD). Franklin Lakes, New Jersey–based BD is evaluating the safety and effectiveness of the stent in its AGILITY FDA investigational device exemption (IDE) trial. The self-expanding, low-profile, polytetrafluoroethylene encapsulated nitinol implant is deployed […]
A high-ranking BD executive is set to retire
BD announced today that its EVP and President of Life Sciences, Dave Hickey, intends to retire this year. Hickey plans for his retirement to go into effect on July 1, 2024. He originally joined BD in 2014, serving as president of Diagnostic Systems. He took over as president of Integrated Diagnostic Solutions in 2019 and […]
BD ups guidance but stock dips on mixed Q1 results
BD shares fell this morning on first-quarter results that came in mixed compared to the consensus forecast. Shares of BD dipped 1.2% at $235.92 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. The Franklin Lakes, New Jersey-based medtech giant posted […]
BD, Techcyte collab on AI-based cervical cytology
BD announced today that it partnered with Techcyte on AI-based guidance for cytologists and pathologists. The strategic collaboration aims to offer an AI algorithm to guide cytologists and pathologists to efficiently and effectively identify evidence of cervical cancer and precancer using whole-slide imaging. Franklin Lakes, New Jersey-based BD said in a news release that the agreement […]
BD inks $85M settlement over Alaris defect disclosure claims
BD announced that it filed settlement documents for an $85 million agreement to resolve claims regarding its Alaris infusion pump technology. The Alaris system has been much maligned over the past few years. Its troubles date back to a Class I recall in early 2020. The recall, which centered around multiple system errors, software errors, […]
FDA clears fingertip blood collection device from BD
BD announced today that the FDA granted 510(k) clearance to its MiniDraw novel blood collection device. Franklin Lakes, New Jersey-based BD’s device obtains blood samples from a fingerstick, producing lab-quality results for commonly ordered blood tests. BD designed MiniDraw as a less invasive device compared to traditional venous blood draw. A trained healthcare worker can […]
BD recalls more Alaris pumps due to compatibility issues with Cardinal Health syringes
The FDA determined that another recall of BD Alaris infusion pumps is Class I, the most serious kind. In the latest Alaris recall, the company cites compatibility issues with Cardinal Health Monoject syringes. The issue mainly relates to changes made to the products by Cardinal Health. It affects more than 1 million total devices. BD’s […]